4556 On Other Exchanges
4556 is not on other exchanges.

kainos laboratories inc (4556) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KAINOS LABORATORIES INC (4556)

Related News

No related news articles were found.

kainos laboratories inc (4556) Related Businessweek News

No Related Businessweek News Found

kainos laboratories inc (4556) Details

KAINOS Laboratories, Inc. develops, manufactures, markets, distributes, and imports/exports pharmaceuticals, diagnostic reagents, related chemical products, physical and chemical measurement instruments, medical supplies, nutrition supplements, foodstuff, animal feed, and related products in Japan. The company offers various biochemical clinical testing reagents systems, such as Aqua-auto Kainos series for automated analysis equipment; MP-EIA series for automated EIA equipment QUARTUS ImmunoCube; Lana 1,5AG, a high-sensitivity diabetes diagnostic reagent and a family of immunoserological testing reagents; MAST, an allergic diagnostic reagent; and Hitazyme Chlamydia for infectious diseases. It also provides FGF-23 ELISA Kit, a two-site enzyme-linked immunosorbent assay kit for the measurement of FGF-23 in serum; and ADAMTS13 ELISA kit that captures ADAMTS13-cleaved products using a sandwich method. In addition, the company offers biochemical diagnostic reagents, including Aqua-auto Kainos UN-II test kit, a liquid form urea nitrogen measurement reagent kit; Aqua-auto Kainos CRE-II test kit, a liquid form creatinine measurement reagent kit; and Aqua-auto Kainos ALB test kit, a liquid form reagent kit. Further, it provides Swiftgene Norovirus GI/GII Kainos for detecting noroviruses; Statmark FLUstick-N for detecting Type A and Type B influenza virus antigens; and Statmark Strep A for detecting Group A-b hemolytic streptococci. The company was formerly known as DOMS-IATRON Co., Ltd. and changed its name to KAINOS Laboratories, Inc. in July 1975. KAINOS Laboratories, Inc. was founded in 1975 and is headquartered in Tokyo, Japan.

Founded in 1975

kainos laboratories inc (4556) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kainos laboratories inc
Kainos Laboratories, Inc. to Report Fiscal Year 2017 Results on May 10, 2017

Kainos Laboratories, Inc. announced that they will report fiscal year 2017 results on May 10, 2017

Kainos Laboratories, Inc., Q3 2017 Earnings Call, Jan 25, 2017

Kainos Laboratories, Inc., Q3 2017 Earnings Call, Jan 25, 2017

Kainos Laboratories, Inc. to Report Q2, 2017 Results on Oct 24, 2016

Kainos Laboratories, Inc. announced that they will report Q2, 2017 results on Oct 24, 2016


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4556 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4556.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4556 Industry Range
Price/Earnings 22.4x
Price/Sales 0.4x
Price/Book 0.7x
Price/Cash Flow 15.1x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KAINOS LABORATORIES INC, please visit www.kainos.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.